IBRX - Comprehensive Filing Intelligence

FY 2025•10-K•Filed Feb 23, 2026
3.0/10
Filing Health:CONCERN

Significant issues identified across multiple dimensions

Executive Summary

Significant contingent liabilities exist, including a potential $164.2 million claim from former Altor shareholders related to ANKTIVA regulatory milestones.. Revenue increased by 668% to $113.3M See detailed pass outputs for comprehensive analysis.

Top Concerns

  • !The company faces substantial going concern risks due to high operating cash outflows, necessitating significant additional funding.
  • !Management expresses mixed tones, highlighting strategic positioning but acknowledging critical funding needs and going concern doubts.
  • !Going concern uncertainty with substantial doubt expressed.
  • !Significant accumulated deficit and negative operating cash flows.
  • !Significant contingent liabilities exist, including a potential $164.2 million claim from former Altor shareholders related to ANKTIVA regulatory milestones.

Top Positives

  • +ANKTIVA commercialization is driving significant revenue growth, with expanding global approvals and pipeline development showing promise.
  • +Increased R&D investment supports future growth, while SG&A decreased due to lower professional services expenses.
  • +Working capital deteriorated due to increases in accounts receivable and inventory, impacting cash flow negatively.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

6.0/10

Management tone is balanced.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

3.0/10

Earnings quality shows aggressive accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is high with $284.7 million in identified exposure.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

2.0/10

Overall risk profile shows regulatory approval uncertainty and increased requirements as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

6.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.